San Diego

September 24, 2025:  Best Practices for Building a Small Biotech

March 19, 2025:  The New Administration & its Potential Impact on our Industry

   Arman Oruc, Partner, Goodwin

   Joe Panetta, President Emeritus, Biocom CA

   Sabrina Johnson, President & CEO, Dare Bioscience

   Stanley Lewis, Founder & CEO, A28 Therapeutics

   Moderated by Sue Crinnion, Managing Director, Life Sciences Venture Banking, Banc of CA

September 25, 2024:  How AI is Changing the Pharma & Biotech Industry

   Bryce Allen, Co-founder & CEO, Differentiated Therapeutics

   Dana Hosseini, Co-founder & CSO, SEQSTER

   Devon Cayer, Founder & CEO, OM

   Jason Ferrone, COO & General Counsel, Creyon Bio

   Tom Miller, Co-founder & CEO, Iambic Therapeutics

   Moderated by Ekaterine Kortkhonjia, Sr. Director, Early Innovation Partnering, Johnson         & Johnson 

March 25, 2024:  The Expanding Role of Pharma in our Ecosystem

   Artie Suckow, CEO, DTx

   Clare Ozawa, Partner, Versant Ventures

   Dan Estes, Partner, Frazier Life Sciences

   Kevin Forrest, CEO, Kate Therapeutics

   Moderated by Aliza Apple, COO & Head of Lilly Gateway Labs West Coast, Lilly 

September 27, 2023:  Implications of the Inflation Reduction Act

   Dina Lynch, Head of Market Access, Alzheon

   Kevin Finney, CEO,  Autobahn Therapeutics

   Matt Wetzel, Partner, Life Sciences, Goodwin

   Sarah Honig, VP, Corporate Development & Strategy, Tyra Biosciences

   Moderated by Mark Spring, Managing Director, Danforth Advisors